Back to Search
STEVEN LARSEN, M.D.
M.D.
Interventional Pain Medicine Physician
NPI: 1235579731IndividualAccepts Medicare
Specialties, Licenses & Credentials
Interventional Pain Medicine PhysicianPrimary
Pain Medicine — Interventional Pain Medicine
Code: 208VP0014X
5495552-1205(UT)
Anesthesiology Physician
Anesthesiology
Code: 207L00000X
5495552-1205(UT)
Education
OREGON HEALTH SCIENCES UNIVERSITY SCHOOL OF MEDICINE
Class of 2015
Research & Publications (20)
Discovery of ligands for the human intestinal Di-/Tripeptide transporter (hPEPT1) using a QSAR-assisted virtual screening strategy.
PMID 19557803·ChemMedChem·2009
7-preclinical
Improved granulocyte colony-stimulating factor mobilization of hemopoietic progenitors using cytokine combinations in primates.
PMID 18719223·Stem Cells·2008
4-observational
On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds.
PMID 18374550·Eur J Pharm Sci·2008
8-other
Assessment of drug release from oil depot formulations using an in vitro model -- potential applicability in accelerated release testing.
PMID 18363145·Drug Dev Ind Pharm·2008
8-other
QSAR models for the human H(+)/peptide symporter, hPEPT1: affinity prediction using alignment-independent descriptors.
PMID 18092768·J Chem Inf Model·2008
8-other
Pyrazole inhibitors of HMG-CoA reductase: an attempt to dramatically reduce synthetic complexity through minimal analog re-design.
PMID 17764936·Bioorg Med Chem Lett·2007
7-preclinical
Quantitative comparison of functional MRI and direct electrocortical stimulation for functional mapping.
PMID 17763497·Int J Med Robot·2007
4-observational
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
PMID 17513108·Bioorg Med Chem Lett·2007
8-other
Diflunisal salts of bupivacaine, lidocaine and morphine. Use of the common ion effect for prolonging the release of bupivacaine from mixed salt suspensions in an in vitro dialysis model.
PMID 17462869·Eur J Pharm Sci·2007
8-other
The adjuvant effect of di-(2-ethylhexyl) phthalate is mediated through a PPARalpha-independent mechanism.
PMID 17462839·Toxicol Lett·2007
7-preclinical
In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration.
PMID 16920337·Eur J Pharm Sci·2006
8-other
Damage to incisors after nonmyeloablative total body irradiation may complicate NOD/SCID models of hemopoietic stem cell transplantation.
PMID 16774130·Comp Med·2006
7-preclinical
Identification and characterization of tandem repeats in exon III of dopamine receptor D4 (DRD4) genes from different mammalian species.
PMID 16332176·DNA Cell Biol·2005
4-observational
Effects of mono-2-ethylhexyl phthalate on the respiratory tract in BALB/c mice.
PMID 15625780·Hum Exp Toxicol·2004
7-preclinical
Adjuvant effect of benzalkonium chloride on the allergen-specific IgE, IgG1 and IgG2a antibody formation in BALB/cJ mice.
PMID 15379788·Basic Clin Pharmacol Toxicol·2004
7-preclinical
Kinetics of degradation and oil solubility of ester prodrugs of a model dipeptide (Gly-Phe).
PMID 15265509·Eur J Pharm Sci·2004
8-other
Adjuvant effect of quaternary ammonium compounds in a murine model.
PMID 15183463·Toxicol Lett·2004
7-preclinical
Kinetics of degradation of 4-imidazolidinone prodrug types obtained from reacting prilocaine with formaldehyde and acetaldehyde.
PMID 14550890·Eur J Pharm Sci·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 617 E RIVERSIDE DR STE 301
SAINT GEORGE, UT 84790 - Phone
- (435) 216-7000
Quick Facts
- NPI
- 1235579731
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 11
- Publications
- 20
Are you this provider?
Claim Your Profile